Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Kennewick › NPI 1952385056
Lab

Tri-Cities Laboratory, LLC

Tri-Cities Laboratory, LLC was paid $8.69M by Medicaid between Jan 2018 and Dec 2021, across 207 billing codes. Its largest line is 80050, General health panel — 7.1% of everything it billed.

33Billing provider infoTRI-CITIES LABORATORY, LLC
KENNEWICK, WA 99336
33aNPI1952385056assigned 12/01/2005
33bProvider typeClinical Medical Laboratory
28Total paid$8.69M
24GClaims744,529
24DCodes billed207
24AFirst – last monthJan 2018 – Dec 2021
Compared with peers

Next to other Clinical Medical Laboratory providers in Washington

Rank by total paid#11 of 76
Median peer was paid$90K
This provider vs. median96×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018218,394$2.55M
2019195,712$2.21M
2020167,164$2.07M
2021163,259$1.86M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80050 General health panel 7.1% 20,566 19,514 $621K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.0% 8,135 7,860 $612K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4.5% 12,640 12,001 $391K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4.5% 12,535 11,891 $388K
86003 4.4% 4,428 2,639 $384K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.2% 54,412 46,087 $367K
80053 Comprehensive metabolic panel 3.9% 37,791 32,148 $336K
80061 Lipid panel 3.5% 26,304 25,155 $304K
36415 Collection of venous blood by venipuncture 2.9% 113,270 98,833 $253K
84443 Thyroid stimulating hormone (TSH) 2.3% 14,611 13,872 $200K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.1% 9,078 8,604 $186K
86480 1.6% 2,711 2,666 $140K
195 more codes
83036 Hemoglobin; glycosylated (A1C) 1.6% 17,102 $136K
87086 Culture, bacterial; quantitative colony count, urine 1.6% 18,660 $135K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.4% 2,234 $124K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.4% 6,327 $121K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.3% 1,389 $116K
87480 1.3% 6,312 $115K
87510 1.3% 6,312 $115K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.3% 3,444 $109K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1.2% 1,708 $105K
87081 1.1% 15,655 $97K
84702 1.1% 7,182 $95K
87660 1.1% 5,155 $94K
86780 1.1% 8,264 $92K
86235 1.0% 1,893 $88K
86803 1.0% 7,492 $87K
84439 <1% 9,721 $77K
82728 <1% 6,225 $75K
87340 <1% 8,702 $75K
83970 <1% 2,054 $69K
84403 <1% 3,240 $69K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 271 $68K
86762 <1% 5,546 $68K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,507 $65K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,864 $63K
82607 <1% 4,242 $55K
87186 <1% 6,230 $48K
83013 <1% 757 $48K
84481 <1% 3,508 $47K
84402 <1% 2,228 $47K
86140 <1% 9,866 $46K
84144 <1% 2,489 $45K
82670 <1% 1,765 $44K
87430 <1% 3,422 $44K
83550 <1% 5,761 $44K
84146 <1% 2,528 $44K
83516 <1% 3,102 $43K
83001 <1% 2,613 $43K
87902 <1% 181 $43K
87522 Neg quan hep c or qual rna <1% 1,105 $42K
85027 <1% 7,091 $39K
86696 <1% 2,164 $37K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 866 $37K
83002 <1% 2,194 $36K
87088 <1% 5,076 $36K
82570 <1% 7,905 $35K
86038 <1% 3,204 $35K
83540 <1% 6,108 $35K
82746 <1% 2,668 $34K
80048 Basic metabolic panel (calcium, ionized) <1% 4,751 $32K
82784 <1% 2,837 $29K
87077 <1% 4,357 $29K
86704 <1% 2,889 $29K
87070 <1% 3,624 $28K
83735 <1% 4,829 $28K
81001 <1% 9,779 $28K
85652 <1% 11,132 $27K
84153 <1% 1,819 $27K
82043 <1% 5,073 $26K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,802 $25K
82105 <1% 1,655 $25K
86695 <1% 2,010 $25K
83520 <1% 1,783 $24K
86706 <1% 2,688 $24K
82627 <1% 1,063 $22K
83655 <1% 1,872 $21K
80074 <1% 641 $21K
80076 <1% 2,999 $21K
86708 <1% 1,889 $21K
86850 <1% 2,925 $19K
82950 <1% 4,503 $19K
86431 <1% 3,016 $18K
86200 <1% 1,441 $17K
80069 <1% 2,569 $17K
86256 <1% 1,061 $16K
84436 <1% 2,686 $16K
82677 <1% 685 $16K
86160 <1% 1,436 $15K
85007 <1% 4,957 $15K
86336 <1% 1,061 $15K
81003 <1% 7,205 $15K
82247 <1% 3,381 $15K
86665 <1% 781 $14K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 40 $14K
86225 <1% 1,072 $13K
82951 <1% 1,119 $13K
83615 <1% 2,533 $13K
84479 <1% 2,226 $12K
87899 <1% 1,180 $12K
84460 <1% 2,625 $12K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,242 $12K
84550 <1% 3,119 $12K
36416 <1% 5,846 $11K
82274 <1% 775 $11K
83883 <1% 932 $11K
84480 <1% 844 $11K
84450 <1% 2,320 $10K
83690 <1% 1,629 $10K
86376 <1% 731 $10K
81025 <1% 1,500 $10K
84156 <1% 3,181 $10K
82465 <1% 2,410 $10K
83880 <1% 326 $9K
82785 <1% 650 $9K
86694 <1% 708 $9K
82248 <1% 2,157 $9K
84703 <1% 1,303 $9K
82533 <1% 583 $9K
86800 <1% 623 $9K
85610 <1% 2,447 $8K
87536 <1% 102 $8K
86900 <1% 2,923 $8K
84100 <1% 1,934 $8K
86901 <1% 2,923 $8K
82378 <1% 414 $7K
87209 <1% 386 $7K
82550 <1% 1,127 $7K
86769 <1% 208 $6K
87046 <1% 689 $6K
82679 <1% 278 $6K
82565 <1% 1,312 $6K
85018 <1% 2,534 $6K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 139 $5K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 156 $5K
87045 <1% 575 $5K
84165 <1% 536 $5K
82947 <1% 1,429 $5K
82977 <1% 758 $5K
82150 <1% 759 $4K
87205 <1% 1,239 $4K
82952 <1% 1,206 $4K
85730 <1% 938 $4K
86787 <1% 332 $4K
83525 <1% 402 $4K
85046 <1% 775 $4K
87338 <1% 293 $4K
80164 <1% 303 $4K
81015 <1% 1,301 $4K
84270 <1% 160 $3K
87177 <1% 385 $3K
86593 <1% 750 $3K
86334 <1% 148 $3K
86141 <1% 233 $3K
80178 <1% 436 $3K
85014 <1% 1,097 $2K
87653 <1% 87 $2K
84520 <1% 627 $2K
87449 <1% 179 $2K
87324 <1% 178 $2K
83498 <1% 81 $2K
86308 <1% 309 $2K
87075 <1% 215 $2K
85379 <1% 156 $2K
84305 <1% 70 $2K
86255 <1% 123 $2K
80051 <1% 230 $1K
87486 <1% 40 $1K
87581 <1% 40 $1K
86709 <1% 99 $1K
87517 <1% 26 $1K
82103 <1% 84 $1K
86039 <1% 88 $1K
87280 <1% 76 $922.72
86663 <1% 66 $907.18
87807 <1% 78 $905.54
86705 <1% 87 $897.72
86664 <1% 54 $876.05
82626 <1% 41 $833.23
82652 <1% 29 $817.25
80177 <1% 63 $804.82
82310 <1% 154 $667.98
86060 <1% 75 $520.25
84425 <1% 24 $464.38
83090 <1% 40 $450.11
87255 <1% 12 $377.54
82024 <1% 13 $377.40
86812 <1% 25 $375.04
80197 <1% 34 $372.95
84163 <1% 28 $369.46
81291 <1% 51 $368.62
87493 <1% 12 $366.52
86682 <1% 52 $319.06
82040 <1% 59 $256.06
82747 <1% 13 $227.26
86361 <1% 13 $224.58
83993 <1% 12 $215.76
86765 <1% 15 $202.20
82140 <1% 14 $195.10
86735 <1% 14 $191.24
87040 <1% 19 $183.50
84154 <1% 13 $182.59
84630 <1% 15 $139.97
87101 <1% 12 $92.04
84478 <1% 19 $85.48
81374 <1% 321 $63.81
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.